These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 212267)

  • 1. Molecular biology of metabolic disease: defects in the regulation of enzymic activity.
    Galton DJ
    Enzyme; 1978; 23(4):274-88. PubMed ID: 212267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defects of enzyme regulation in metabolic disease.
    Galton DJ; Betteridge DJ; Taylor KG; Holdsworth G; Stocks J
    Clin Sci Mol Med; 1977 Sep; 53(3):197-203. PubMed ID: 199395
    [No Abstract]   [Full Text] [Related]  

  • 3. Errors in metabolic regulation. A common group of metabolic disorders.
    Galton DJ; Higgins MJ; Reckless JP
    Lancet; 1975 May; 1(7918):1224-6. PubMed ID: 48840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new type of familial hypercholesterolaemia.
    Higgins MJ; Lecamwasam DS; Galton DJ
    Lancet; 1975 Oct; 2(7938):737-40. PubMed ID: 52771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia.
    Gianturco SH; Gotto AM; Jackson RL; Patsch JR; Sybers HD; Taunton OD; Yeshurun DL; Smith LC
    J Clin Invest; 1978 Feb; 61(2):320-8. PubMed ID: 202612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions.
    Vaziri ND; Liang K; Azad H
    J Pharmacol Exp Ther; 2000 Aug; 294(2):778-83. PubMed ID: 10900260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and biochemical study of 2 cases of lipomatosis].
    Jamin C; Pecquery R; Fingerhut A; Giudicelli Y; Quevauvilliers J; Nenna A
    Nouv Presse Med; 1977 Jun; 6(23):2043-7. PubMed ID: 887402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal regulation of the LDL-R and HMG CoA reductase genes in subjects with familial hypercholesterolemia with the "French Canadian mutation".
    Yu L; Qiu S; Genest J
    Atherosclerosis; 1996 Jul; 124(1):103-17. PubMed ID: 8800498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic lesion in familial hypercholesterolaemia.
    Myant NB
    Expos Annu Biochim Med; 1977; 33():39-52. PubMed ID: 196909
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of (-)-hydroxycitrate on the activity of the low-density-lipoprotein receptor and 3-hydroxy-3-methylglutaryl-CoA reductase levels in the human hepatoma cell line Hep G2.
    Berkhout TA; Havekes LM; Pearce NJ; Groot PH
    Biochem J; 1990 Nov; 272(1):181-6. PubMed ID: 2176080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: evidence for the regulation of enzymic activity by a bicyclic phosphorylation cascade.
    Beg ZH; Stonik JA; Brewer HB
    Biochem Biophys Res Commun; 1984 Mar; 119(2):488-98. PubMed ID: 6324764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Errors in metabolic regulation. A regulatory defect in the human adipocyte.
    Galton DJ
    S Afr Med J; 1975 Mar; 49(13):469-72. PubMed ID: 167459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biochemistry of familial hypercholesterolaemia.
    Myant NB
    Biochem Soc Trans; 1976; 4(4):580-4. PubMed ID: 187482
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts by reversible phosphorylation: modulation of enzymatic activity by low density lipoprotein, sterols, and mevalonolactone.
    Beg ZH; Reznikov DC; Avigan J
    Arch Biochem Biophys; 1986 Jan; 244(1):310-22. PubMed ID: 3004340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of low density lipoprotein receptor and 3-hydroxy-3-methyl-glutaryl-CoA reductase activities are differentially affected in Niemann-Pick type C and type D fibroblasts.
    Sidhu HS; Rastogi SA; Byers DM; Guernsey DL; Cook HW; Palmer FB; Spence MW
    Biochem Cell Biol; 1993; 71(9-10):467-74. PubMed ID: 8192899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daio-Orengedokuto inhibits HMG-CoA reductase and pancreatic lipase.
    Kim YS; Jung EA; Shin JE; Chang JC; Yang HK; Kim NJ; Cho KH; Bae HS; Moon SK; Kim DH
    Biol Pharm Bull; 2002 Nov; 25(11):1442-5. PubMed ID: 12419956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of increased HMG-CoA reductase gene expression to hypercholesterolemia in experimental chronic renal failure.
    Chmielewski M; Sucajtys E; Swierczynski J; Rutkowski B; Bogusławski W
    Mol Cell Biochem; 2003 Apr; 246(1-2):187-91. PubMed ID: 12841361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Homozygote familial hypercholesterinemia. Pathophysiology and genetic control of cholesterol metabolism].
    Gaertner U
    Med Klin; 1978 Jun; 73(23):849-54. PubMed ID: 207958
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of hepatic hydroxy methyl glutarate - CoA reductase for controlling hypercholesterolemia in rats.
    Khamis AA; Salama AF; Kenawy ME; Mohamed TM
    Biomed Pharmacother; 2017 Nov; 95():1242-1250. PubMed ID: 28938515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cholesterol metabolism and low-density lipoprotein binding in human intestinal Caco-2 cells.
    Reimann FM; Herold G; Grosshans I; Rogler G; Fellermann K; Stange EF
    Digestion; 1992; 51(1):10-7. PubMed ID: 1639221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.